Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan

Kazumasa Sakamoto1, Kiyoaki Ito2, Hiroshi Yotsuyanagi3,4

  • 1Department of Gastroenterology, Aichi Medical University, 1-1, Yazakokarimata, Nagakute, Aichi, 480-1195, Japan.

Journal of Gastroenterology
|September 29, 2022
PubMed

Insights

Hepatitis B virus (HBV) genotype distribution in Japan shows shifting trends. Genotypes B and C are peaking in older adults, while genotype A is increasing in younger individuals.

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • Hepatitis B virus (HBV) causes chronic hepatitis B (CHB), a prevalent global infection.
  • Genotypes B and C are dominant in Japan, but genotype A prevalence has shown a gradual increase.
  • Nationwide data is needed to understand current HBV genotype distribution trends in Japan.

Purpose of the Study:

  • To investigate the nationwide trends of HBV genotype distribution in chronic hepatitis B patients in Japan.
  • To compare the distribution of HBV genotypes across different age groups over time.
  • To establish a baseline for assessing the impact of universal HBV vaccination on genotype prevalence.

Main Methods:

  • A nationwide survey of 4421 CHB patients recruited between 2015 and 2016.
  • Comparison of clinical characteristics and genotype distribution with data from 2000-2001, 2005-2006, and 2010-2011.
  • Analysis of HBV genotype percentages (A, B, C, D) and age-specific distribution.

Main Results:

  • Genotype distribution: A (4.0%), B (16.2%), C (79.1%), D (0.7%).
  • CHB with genotype A increased in young adults, despite no overall change in its prevalence.
  • Peak distribution for genotypes B and C shifted to older age groups.

Conclusions:

  • In Japan, CHB genotypes B and C show a trend towards older age groups, while genotype A is expanding in younger populations.
  • These pre-vaccination data are crucial for future studies on the impact of universal HBV vaccination on genotype epidemiology.
  • Understanding these shifts is vital for public health strategies and HBV control in Japan.
Abstract